In a joint technical report published in 2009, ‘The bacterial challenge: time to react’, the European Medicines Agency (EMA) and the European Centre for Disease Prevention and Control (ECDC) estimate the cost of antimicrobial resistance in humans to be annually EUR 1,5 billion. As follow-up to this estimation of EMA and ECDC, and to better demonstrate the impact of antimicrobial resistance, an appropriate economic analysis is needed by a recognised partner such as OECD to be used as support of the policy proposals.
Recital 22, Commission Implementing Decision of 14 June 2013 concerning the financing for the year 2…
In forcesince 14 Jun 2013